Regulatory NewsBREAK: CMS Issues Final Notice on Transitional Coverage for Emerging Technologies
On Aug. 12, 2024, the Centers for Medicare and Medicaid Services (CMS) issued a Final Notice on Transitional Coverage for Emerging Technologies (Final Notice). This notice describes how CMS will use the national coverage determination (NCD) and Coverage with Evidence Development (CED) processes to provide transitional coverage for emerging technologies (TCET), for certain Breakthrough Devices that are Food and Drug Administration (FDA) market authorized. Access the Regulatory NewsBREAK to learn more.
Related
On January 17, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the list of 15 additional Part D drugs for the Medicare Drug Price Negotiation Program.
In January 2025, the U.S. Department of Health and Human Services (HHS) issued a Strategic Plan for the Use of Artificial Intelligence in Health, Human Services, and Public Health in efforts to use AI responsibly to improve people's lives.
On December 20, 2024, the Centers for Medicare & Medicaid Services (CMS) issued explanations for the maximum fair prices (MFPs) for the drugs selected for the IRA’s Medicare Drug Price Negotiation Program for the initial price applicability year (IPAY) 2026.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
